Sales Vision – the “Pharmacentric ” SFE and CRM tool
Innovation.
Sales Vision is the most innovative CRM solution for the life-science industry. Our native iPad and iPhone Pharma CRM app is available on the Apple AppStore. Additional Sales Vision also runs as an native Windows app, web app, Android app and Windows Mobile. Shortly we cover all relevant platforms for pharma with native and offline solutions.
Flexibility and designs.
Sales Vision is amazing flexible inside the system where you can manage everything in several steps in the powerful admin tool. Outside Sales Vision we enable a wide customization for our customers in terms or modules and business processes. Design is our package. We want perfection in terms of user interfaces, navigation and usage. Our applications are designed with the help of famous design agencies.
Cost Efficient.
In the last three years Sales Vision is becoming one of the leading global life-science CRM solutions. Our price strategy is fair and efficient and indeed different and fair to our customers.
Salvis Pharma Bulgaria selects Sales Vision CRM
Salvis Pharma Bulgaria, the leading OTC and food supplement company in Bulgaria has selected Sales Vision Pharma CRM.
Salvis is the Novartis OTC distributor and has some really specific and unique business processes which have been integrated into Sales Vision. On the field Salvis will operate with the mobile solution from Sales Vision which integrates the [...]
Sales Vision Android. Revolution again.
Once again we are creating a revolution with our new flagship product Sales Vision Android. After the Sales Vision iTouch, the ultimate Pharma CRM solution for iPad and iPhone we present the global first offline/online Pharma CRM and SFE tool for pharmaceuticals. With Sales Vision Android your sales team can work with local data on [...]
Cadila Healthcare to Buy Assets of Nesher
BANGALORE—Cadila Healthcare Ltd., a part of the Zydus Group, Friday said its U.S. unit has agreed to acquire the assets of U.S.-based pharmaceutical company Nesher Pharmaceuticals Inc. for an undisclosed amount.
Cadila Healthcare said the acquisition of Nesher—the generic unit of KV Pharmaceutical-will allow its U.S. unit to make and sell generic controlled [...]
Pfizer Enters Into Agreement to Acquire 40 Percent Stake in Teuto in Brazil
Pfizer Inc. (NYSE: PFE) announced today that it is entering into a partnership with Laboratorio Teuto Brasileiro S.A., a leading company in the Brazilian generics industry, to develop and commercialize generic medicines. Pfizer will acquire a 40 percent stake in Teuto and the companies will also enter into a series of commercial agreements. The partnership [...]
